These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23294798)

  • 61. The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
    Limbu Y; Torres IM
    J Health Hum Serv Adm; 2009; 32(1):107-38. PubMed ID: 19558035
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Examining the FDA's oversight of direct-to-consumer advertising.
    Gahart MT; Duhamel LM; Dievler A; Price R
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prescription drug coupons: evolution and need for regulation in direct-to-consumer advertising.
    Mackey TK; Yagi N; Liang BA
    Res Social Adm Pharm; 2014; 10(3):588-94. PubMed ID: 24120330
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
    Greene JA; Watkins ES
    N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
    [No Abstract]   [Full Text] [Related]  

  • 66. Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Southwell BG; Rupert DJ
    Int J Health Policy Manag; 2016 Jan; 5(3):211-3. PubMed ID: 26927597
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD; Kleit AN; Nietert PJ; Ornstein S
    Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
    Smirniotopoulos A
    Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Electronic direct-to-consumer advertising of pharmaceuticals: an assessment of textual and visual content of websites.
    Alkazemi MF; Van Stee SK
    Health Educ Res; 2020 Apr; 35(2):134-151. PubMed ID: 32144424
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws.
    Nathenson R; Richards MR
    Int J Health Econ Manag; 2018 Sep; 18(3):321-336. PubMed ID: 29380108
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thinking outside the medicine cabinet: a comparative content analysis of direct-to-consumer advertisements for prescription drug treatments.
    McKeever R
    Health Mark Q; 2014; 31(4):353-69. PubMed ID: 25405635
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suspect online sellers and contraceptive access.
    Liang BA; Mackey TK; Lovett KM
    Contraception; 2012 Nov; 86(5):551-6. PubMed ID: 22633248
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Health outcomes in patients using no-prescription online pharmacies to purchase prescription drugs.
    Cicero TJ; Ellis MS
    J Med Internet Res; 2012 Dec; 14(6):e174. PubMed ID: 23220405
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An examination of selected drug availability at online pharmacies.
    Koong KS; Koong LY; Liu LC; Yu M
    Int J Electron Healthc; 2005; 1(3):291-302. PubMed ID: 18048211
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The federal regulation of prescription drug advertising and promotion.
    Kessler DA; Pines WL
    JAMA; 1990 Nov; 264(18):2409-15. PubMed ID: 2231998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Direct-to-consumer advertising of pharmaceuticals.
    Gellad ZF; Lyles KW
    Am J Med; 2007 Jun; 120(6):475-80. PubMed ID: 17524744
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ensuring access to prescription medications in the post-ACA healthcare access landscape: the essential role of FQHCs in the safety net for the underinsured.
    Shi L; Wharton MK; Monnette A
    Am J Manag Care; 2018 Mar; 24(5 Suppl):S67-S73. PubMed ID: 29620813
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Searching online to buy commonly prescribed psychiatric drugs.
    Monteith S; Glenn T
    Psychiatry Res; 2018 Feb; 260():248-254. PubMed ID: 29220682
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The past, present, and future of direct-to-consumer prescription drug advertising.
    Perri M; Shinde S; Banavali R
    Clin Ther; 1999 Oct; 21(10):1798-811; discussion 1797. PubMed ID: 10566574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preparing a prescription drug monitoring program data set for research purposes.
    O'Kane N; Hallvik SE; Marino M; Van Otterloo J; Hildebran C; Leichtling G; Deyo RA
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):993-7. PubMed ID: 27273809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.